Clinical Trial Update: Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency

View source ↗

Summary

Clinical trial update shows safety and efficacy data for Fibryga in congenital fibrinogen deficiency; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Fibrinogen Deficiency

Drugs mentioned

• Fibryga (human fibrinogen concentrate)

Snippet

Sponsor: Octapharma | Conditions: Congenital Fibrinogen Deficiency | Status: TERMINATED